tattoo toxic to body

WHAT EXACTLY ARE WE INJECTING?
Way back in the day, traditional tribal tattoo marks were made using dyes from the natural environment. This is certainly not the case any more. While it’s near impossible to say what’s in all tattoo inks (they are all different, and disclosure of ingredients is not actually enforced), it’s safe to say that most colours of standard tattoo ink are derived from heavy metals.
Mercury = red ink
Lead = yellow, green, white ink
Cadmium = red, orange, yellow ink
Nickel = black ink
Zinc= yellow, white ink
Chromium = green ink
Cobalt = blue ink
Aluminium = green, violet ink
Titanium = white ink
Copper = blue, green ink
Iron = brown, red, black ink
Barium = white ink

Other compounds used as pigments include antimony, arsenic, beryllium, calcium, lithium, selenium, and sulphur.
Tattoo ink manufacturers typically blend the heavy metal pigments and/or use lightening agents (such as lead or titanium) to reduce production costs.
Why are heavy metals such a problem? They bind in our bodies and are incredibly difficult to remove. They cause damage on a cellular level and contribute to cancer, Alzheimer’s, dementia, autoimmune diseases, rheumatoid arthritis, and diseases of the kidneys, circulatory system, and nervous system.
Then there’s the carrier solution, which most likely contains harmful substances such as denatured alcohols, methanol, rubbing alcohol, antifreeze, detergents, or formaldehyde and other highly toxic aldehydes.

HOW CAN WE RECTIFY THE DAMAGE?
1. Stop getting tattoos.
2. If you’re a tattoo lover, ask to be decorated in high-quality vegan, organic inks and quiz the tattoo artist about the ingredients in the ink. Be adamant that you do not want ink containing heavy metals. Do your research first!
3. Start detoxifying those heavy metals.

Nanoparticles that precisely target tumours are here

IANS | New York

June 9, 2014 Last Updated at 16:16 IST

Add to My Page

Read more on: Nanoparticles That Precisely Target Tumours Are Here

Related News

In a major breakthrough, scientists have designed nanoparticles that can deliver drugs directly to a tumour.
But what makes it special is that those nanoparticles that do not hit their target can be broken down and eliminated easily.
The nanoparticle is encased in a shell coated with a peptide that enables it to target tumour cells.
"The disassembly is an interesting concept for creating drugs that respond to a certain stimulus," said Gary Braun, a post-doctoral associate in the Ruoslahti Lab at University of California, Santa Barbara.
It also minimises the off-target toxicity by breaking down the excess nanoparticles so that they can then be cleared through the kidneys, he added.
The method for removing nanoparticles unable to penetrate target cells is unique.
"By focusing on the nanoparticles that actually got into cells, we can then understand which cells were targeted and study the tissue transport pathways in more detail," Braun explained.
Some drugs are able to pass through the cell membrane on their own, but many drugs, especially RNA and DNA genetic drugs, are charged molecules that are blocked by the membrane.
These drugs must be taken in through endocytosis, the process by which cells absorb molecules by engulfing them.
"This typically requires a nanoparticle carrier to protect the drug and carry it into the cell," Braun noted.
"And that is what we measured - the internalisation of a carrier via endocytosis," he said.
Because the nanoparticle has a core shell structure, the researchers can vary its exterior coating and compare the efficiency of tumour targeting and internalisation.
The findings appeared in the journal Nature Materials.

depresson-problem is going to be solved in the days to come.

Tiny molecule will end trial and error era for depression treatment

BY admin | June 9, 2014

Tiny molecule will help find right medication for depression. The trial and error era will end in treating people suffering from depression
Very small molecules miR-1202 are hard to find in the brains of those people who are suffering from depression. These molecules actually help the brains fight depression and lack of them actually causes depression.

This is going to help many people get right treatment. This will also help physicians in finding people who may be cured when treated by antidepressant medication.

Dr Gustavo Turecki, one of the lead authors of the report say, “Using samples from the Douglas Bell-Canada Brain Bank, we examined brain tissues from individuals who were depressed and compared them with brain tissues from psychiatrically healthy individuals”. Dr Gustavo Turecki is a psychiatrist at the Douglas and professor in the Faculty of Medicine, Department of Psychiatry at McGill. The study has been jointly conducted by scientists at McGill University and the Douglas Institute

Researchers are of the opinion that depression caused disability in many cases and notwithstanding the fact that there are ready treatments for the problem, finding right medication is the most important problem.

They say that physicians make numerous mistakes while treating such patients and many a times aggravate the problem. But the problem is going to be solved in the days to come. Turecki says, “We identified this molecule, a microRNA known as miR-1202, only found in humans and primates and discovered that it regulates an important receptor of the neurotransmitter glutamate”.

While detailing his finding further Turecki further says, “In our clinical trials with living depressed individuals treated with citalopram, a commonly prescribed antidepressant, we found lower levels in depressed individuals compared to the non-depressed individuals before treatment…Clearly, microRNA miR-1202 increased as the treatment worked and individuals no longer felt depressed”. This is a huge development and will help millions of people suffering from depression.